<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02783911</url>
  </required_header>
  <id_info>
    <org_study_id>5140262</org_study_id>
    <nct_id>NCT02783911</nct_id>
  </id_info>
  <brief_title>Comparison of Mineral Trioxide Aggregate (MTA) &amp; Ferric Sulfate (FS) Pulpotomies</brief_title>
  <official_title>Comparison of Clinical and Radiographic Success Between Mineral Trioxide Aggregate (MTA) &amp; Ferric Sulfate (FS) Pulpotomies for Primary Molars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of clinical and radiographic success between Mineral Trioxide Aggregate and Ferric
      Sulfate pulpotomies for primary molars. Recall appointments are completed 6 months, 9 months
      and 12 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of clinical and radiographic success between Mineral Trioxide Aggregate and Ferric
      Sulfate pulpotomies for primary molars. Recall appointments are completed 6 months, 9 months
      and 12 months. Regular recall and follow up will be performed for patients who has MTA or FS
      pulpotomies. Clinical and radiographic findings will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the clinical and radiographic success between Mineral Trioxide Aggregate (MTA) &amp; Ferric Sulfate (FS) pulpotomies in primary molars</measure>
    <time_frame>1 year</time_frame>
    <description>At recall visits 6,9,12 months, blinded clinical examination will be completed by participating faculty members who are calibrated to clinical scaring criteria. Periapical radiographs will be taken and evaluated by 2 pediatric dentists and 1 endodontist, for presence of various pathologies. Scored based on the criteria established by Zurn and Seale 2008. Scores will be transferred to Microsoft Excel. The difference between the two materials will be analyzed using the Mann-Whiteney U test, chi-square test and Fisher's exact test. Intra- and inter-rater agreement will be measured for radiographic assessment using Cohen's kappa test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Primary Teeth</condition>
  <condition>Pulpotomy</condition>
  <arm_group>
    <arm_group_label>Mineral Trioxide Aggregate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject with pulpotomy treated with MTA MTA paste (&lt; 1gm) will be placed on pulp orifice once for the life of the primary teeth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ferric Sulfate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject with pulpotomy treated with FS FS paste (&lt;1gm) will placed on pulp orifice once for 15 secs and removed on primary teeth</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MTA</intervention_name>
    <description>Mineral Trioxide Aggregate grey paste</description>
    <arm_group_label>Mineral Trioxide Aggregate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferric Sulfate</intervention_name>
    <description>Ferric Sulfate paste</description>
    <arm_group_label>Ferric Sulfate</arm_group_label>
    <other_name>FS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I,II

          -  Primary Molars diagnosed with normal or reversible pulpitis with vital carious pulp
             exposures

          -  Teeth that can have hemostasis can be achieved with pressure

          -  No clinical symptoms

          -  No radiographic signs of internal resorption or external root resorption

        Exclusion Criteria:

          -  Primary Molars diagnosed with irreversible pulpitis or necrotic pulp

          -  Teeth that can not achieve hemostasis

          -  Teeth with abscess or fistula

          -  Teeth that have radiographic signs of internal resorption or external resorption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jung-Wei Chen, DDS,MS,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University</affiliation>
  </overall_official>
  <reference>
    <citation>Asgary S, Shirvani A, Fazlyab M. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis. J Clin Pediatr Dent. 2014 Fall;39(1):1-8. Review.</citation>
    <PMID>25631717</PMID>
  </reference>
  <results_reference>
    <citation>Yildirim C, Basak F, Akgun OM, Polat GG, Altun C. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up. J Clin Pediatr Dent. 2016 Winter;40(1):14-20. doi: 10.17796/1053-4628-40.1.14.</citation>
    <PMID>26696101</PMID>
  </results_reference>
  <results_reference>
    <citation>Stringhini Junior E, Vitcel ME, Oliveira LB. Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol. Eur Arch Paediatr Dent. 2015 Aug;16(4):303-12. doi: 10.1007/s40368-015-0174-z. Epub 2015 Apr 2. Review.</citation>
    <PMID>25833280</PMID>
  </results_reference>
  <results_reference>
    <citation>Frenkel G, Kaufman A, Ashkenazi M. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up. J Clin Pediatr Dent. 2012 Winter;37(2):137-41.</citation>
    <PMID>23534318</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2016</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Jung-Wei Chen, DDS, MS, PhD</investigator_full_name>
    <investigator_title>Pediatric Dental Director</investigator_title>
  </responsible_party>
  <keyword>Clinical and Radiograph</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ferric Compounds</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

